(2013), especially in the case of haplotype B (0.287 vs. 0.288) (Table 2), which was suggested bearing risk for PSP because of increased activity of EIF2AK3 (Liu et al., 2012). This evidence concerns the gene EIF2AK3 and supranuclear palsy, progressive, 1.